Durham, NC, United States of America

Lee M Katrincic

This inventor holds 1 USPTO granted patent. Top assignee: Achillion Pharmaceuticals, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee M Katrincic. Retrieved from https://idiyas.com/inventor/lee-m-katrincic-88x4qog4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lee M Katrincic: Innovator in Pharmaceutical Efficacy

Introduction

Lee M Katrincic is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of Complement factor D inhibitors. His work focuses on enhancing therapeutic efficacy and dosage form stability.

Latest Patents

Katrincic holds a patent for "Morphic forms of danicopan." This invention provides stable, highly crystalline forms of Complement factor D inhibitors, specifically Compound 1. The innovation aims to improve therapeutic pharmaceutical efficacy and dosage form stability, which is crucial for effective treatment.

Career Highlights

Katrincic is associated with Achillion Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the company's research and product offerings.

Collaborations

Katrincic has collaborated with notable colleagues, including Avinash S Phadke and Akihiro Hashimoto. These partnerships have contributed to the success of his projects and the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Lee M Katrincic is a distinguished inventor whose work in pharmaceutical efficacy has made a significant impact. His contributions continue to shape the future of therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…